The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice The emerging field of behavioral cardiology by Rozanski, Alan et al.
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Observational studies indicate that psychologic factors strongly influence the course of
coronary artery disease (CAD). In this review, we examine new epidemiologic evidence for
the association between psychosocial risk factors and CAD, identify pathologic mechanisms
that may be responsible for this association, and describe a paradigm for studying positive
psychologic factors that may act as a buffer. Because psychosocial risk factors are highly
prevalent and are associated with unhealthy lifestyles, we describe the potential role of
cardiologists in managing such factors. Management approaches include routinely screening
for psychosocial risk factors, referring patients with severe psychologic distress to behavioral
specialists, and directly treating patients with milder forms of psychologic distress with brief
targeted interventions. A number of behavioral interventions have been evaluated for their
ability to reduce adverse cardiac events among patients presenting with psychosocial risk
factors. Although the efficacy of stand-alone psychosocial interventions remains unclear, both
exercise and multifactorial cardiac rehabilitation with psychosocial interventions have dem-
onstrated a reduction in cardiac events. Furthermore, recent data suggest that psychophar-
macologic interventions may also be effective. Despite these promising findings, clinical
practice guidelines for managing psychosocial risk factors in cardiac practice are lacking.
Thus, we review new approaches to improve the delivery of behavioral services and patient
adherence to behavioral recommendations. These efforts are part of an emerging field of
behavioral cardiology, which is based on the understanding that psychosocial and behavioral
risk factors for CAD are not only highly interrelated, but also require a sophisticated health
care delivery system to optimize their effectiveness. (J Am Coll Cardiol 2005;45:637–51)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.005© 2005 by the American College of Cardiology Foundation
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sarious lifestyle behaviors promote the development and
linical manifestations of coronary artery disease (CAD),
ncluding an unhealthy diet, physical inactivity, and smok-
ng. Emotional factors and the experience of chronic stress
lso promote atherosclerosis and cardiac events, as previ-
usly reviewed (1). However, although cardiologists are
ccustomed to managing lifestyle behaviors such as overeat-
ng and physical inactivity, they are less likely to assess and
reat psychosocial risk factors, perhaps because of their
imited familiarity with effective strategies and recommen-
ations. A potential dilemma is that, on the one hand, it is
ot the function of cardiologists to serve as mental health
rofessionals; on the other hand, the strong and robust
elationship between psychosocial risk factors and CAD
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uman Development and Health, Harvard School of Public Health, Boston,g
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Manuscript received September 29, 2004, accepted October 6, 2004.uggests that cardiologists need to be proactive in addressing
his important aspect of patient care. What then should the
ardiologist’s role be? Herein, we address the question of the
ole of the cardiologist by exploring various ways for
ffective clinical involvement. We also provide an update on
he epidemiologic and pathophysiologic evidence linking
sychosocial factors and the progression of CAD, empha-
izing recent select studies rather than providing a compre-
ensive review, and suggesting areas for future research.
hus, this review is designed to provide an integrated
nderstanding of how psychosocial risk factors influence the
urrent and future practice of cardiology.
PIDEMIOLOGY
sychosocial factors that promote atherosclerosis and ad-
erse cardiac events can be divided into two general cate-
ories: emotional factors and chronic stressors. Emotional
actors include affective disorders such as major depression
nd anxiety disorders as well as hostility and anger. Chronic
tressors include factors such as low social support, low
ocioeconomic status, work stress, marital stress, and care-
iver strain.
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Psychosocial Factors and CAD March 1, 2005:637–51motional factors. Among emotional factors, depression
as been most studied in recent years. Depressive disorders
ary from mild (subclinical) depressive symptoms to classic
ajor depression. According to the Diagnostic and Statistical
anual of Mental Disorders-4th edition, depression is char-
cterized by severely depressed mood and/or anhedonia
inability to take pleasure in life) that lasts for two weeks or
ore and is accompanied by significant functional impair-
ent and somatic complaints. Research in this area has
valuated the effects of depression in both initially healthy
ndividuals and in patients with known CAD. Depression
lays a role in promoting CAD events in both cohorts (1).
ost epidemiologic studies have primarily assessed depres-
ive symptoms rather than major depression. Data indicate
he presence of a strong consistent gradient between the
evel of depressive symptoms and the likelihood of adverse
ardiac events, beginning at relatively low levels of depres-
ive symptoms (2) (Fig. 1). Such data suggest that the
athophysiologic effects of depression may be triggered by
ven mild subclinical symptoms.
Major depression has been studied less commonly, partly
ecause its identification requires a formal interview per-
ormed by trained professionals. However, consistent with
he evidence derived from assessing symptom measures,
ajor depression has also been found to be associated with
highly significant increase in adverse cardiac events, over
Abbreviations and Acronyms
CAD  coronary artery disease
HPA  hypothalamic-pituitary-adrenocorticol
MI  myocardial infarction
SES  socioeconomic status
SSRI  selective serotonin reuptake inhibitor
PET  positron emission tomography
igure 1. Post-myocardial infarction (MI) patients were recruited and
ssigned to one of four categories based on the Beck Depression Inventory
BDI), ranging from no depressive symptoms (BDI 5) to moderate to
evere depressive symptoms (BDI 19). During the five-year follow-up
eriod, a gradient relationship was observed between the magnitude ofs
epressive symptoms and the frequency of deaths, with increased events
ccurring even in patients with mild depressive symptoms (BDI 5 to 9) (2).nd above that observed for the presence of depressive
ymptoms alone (3).
Epidemiologic studies have also considered two other
motional factors relative to prognosis: anxiety and anger/
ostility. Those that have examined the risk of cardiovas-
ular outcomes associated with anxiety disorders are limited.
hree large studies have shown a significant relationship
etween phobias and sudden cardiac death (1), but data
inking other forms of anxiety to CAD are relatively scant or
onflicting and more work is needed. Although hostility and
hronic anger have been linked to cardiovascular outcomes
n a number of studies, results have been generally mixed.
everal factors may contribute to inconsistent findings in
his area. Measures used to assess anger and hostility have
aried widely, making it difficult to compare results. A
ecent study suggests that there is some self-denial and lack
f self-awareness associated with self-reported hostility (4).
his may be overcome by using a structured interview
pproach (4), but the approach has not been widely tested.
nterestingly, a number of recent studies have demonstrated
relationship between hostility or anger and measurements
f subclinical atherosclerosis (5–8) and also have linked
ostility to progression of atherosclerosis during serial cor-
nary angiography (9). Such findings suggest that hostility
nd chronic anger merit further study as potential psycho-
ocial risk factors.
hronic stressors. A variety of adverse life circumstances
hat promote chronic stress have been evaluated for their
elationship to adverse cardiac outcomes. For instance,
hereas the presence of high levels of social support is
nown to promote psychologic and physical well being, a
onsistent literature indicates that low levels of social sup-
ort are health damaging. Although historically there has
een little integration of differing theories of social support,
here is increasing agreement that social support can be
ivided into two broad categories: social networks, which
escribe the size, structure, and frequency of contact with
he network of people surrounding an individual; and
unctional support, which may be further divided into
eceived social support, which highlights the type and
mount of resources provided by the social network, and
erceived social support, which focuses on the subjective
atisfaction with available support or the perception that
upport would be available if needed. Received and per-
eived social support are often further delineated by type,
ncluding instrumental (e.g., help getting tangible tasks
one), financial (economic support), informational (provid-
ng needed information), appraisal (help evaluating a situ-
tion), and emotional support (e.g., providing emotional
upport, feelings of being loved). The term “tangible sup-
ort” also is used to describe types of support that are readily
een or quantified, such as instrumental or financial support.
oth inadequate structural and functional support have been
onsistently linked to the occurrence of cardiac death and
ll-cause mortality in many studies (1). For example, low
tructural support has been associated with increased mor-
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March 1, 2005:637–51 Psychosocial Factors and CADality within cardiac populations, including such factors as
iving alone (10), lacking a confidant (11), and suffering
rom social isolation (12). Furthermore, low emotional
upport (13), lack of available support (14), and low per-
eived social support (15) also have been associated with
ncreased mortality, and preliminary evidence suggests that
unctional support may be more important than structured
upport in cardiac populations (16). As with depression, a
trong and consistent inverse gradient consistently charac-
erizes the relationship between the magnitude of social
upport and adverse clinical outcomes among both initially
ealthy subjects and those with known CAD (1).
Socioeconomic status (SES), generally characterized as a
omposite of factors such as occupational status, economic
esources, education, and social status, has also attracted
ttention because longitudinal studies indicate a strong
nverse gradient between SES level and adverse cardiac
vents. Low SES is characteristically accompanied by poorer
ealth habits and higher frequencies of coronary risk factors,
hich account for half or less of the SES-CAD gradient
17). More financial hardship, poorer housing conditions,
nd increased levels of chronic stress also characterize low
ES, as does poorer and more physically repetitious working
onditions and less job security and job latitude (17). Thus,
ow SES can be viewed as a composite chronic psychologic
tressor (18), a perspective that is supported by pathophys-
ologic evidence. Hypothalamic-pituitary-adrenal (HPA)
ysfunction frequently accompanies chronic stress, and in-
reased dysfunction is observed as SES levels decline. For
xample, this relationship has been documented by an
nverse relationship between SES levels and measurements
f cortisol variability (more variability being healthy) and
easurements of central obesity (19).
Work stress is another form of chronic stress that has
igure 2. Two leading conceptual models of work stress. In the job strain
odel (left), the amount of job demand and decision latitude determines
he degree of job strain. High demand but low decision latitude charac-
erizes job strain. In the effort-reward imbalance model (right), increased
ob effort may result from either extrinsic demands or personal overcom-
itment, and “reward” may occur in the form of money, recognition,
restige, security, or career opportunities. High effort with low reward
haracterizes job imbalance.een increasingly studied for its potential adverse cardiovas- tular effects. Various aspects of work stress have been
tudied, but two leading epidemiologic models have re-
eived the most attention (Fig. 2). One model is the “job
train” model developed by Karasek et al. (20), in which
ndividuals are evaluated according to two factors: “job
emand” and “job latitude.” Individuals with high job
emand but low job latitude are categorized as being under
job strain,” performing excessive routine work with a lack
f creative outlets or a sense of rigid confinement. The other
odel is the effort-reward imbalance model developed by
iegrist et al. (21), but extensively evaluated so far only in
urope. In this model, job “effort” is compared with job
reward,” with effort measured in terms of either extrinsic
emands (e.g., having a demanding employer) or one’s
ntrinsic pattern of responding to work demands, and
ewards measured in terms of financial incentive, self-
steem, career opportunity, or security. Three lines of
vidence link work stress to adverse clinical outcomes. First,
n increasing epidemiologic literature indicates that job
train and effort-reward imbalance (22–25), as well as other
ork parameters (26–28), are associated with an increased
requency of adverse clinical outcomes. Both the job strain
nd effort-reward imbalance model appear comparable for
heir ability to predict adverse events (25). Second, work
arameters, such as low job control, account for a substantial
ortion of the inverse gradient noted between SES status
nd cardiovascular disease (17). Third, several recent studies
ave also linked work stress to measures of subclinical
therosclerosis (29–31), with findings varying between gen-
ers and/or among ethnic groups (30,31). Because most
pidemiologic studies that showed an association between
ork stress and adverse clinical outcomes have focused
rimarily on white men, prospective studies in women and
ther ethnic groups are needed.
Marital stress also represents a chronic stressor with
pparent pathophysiologic effects (27,32,33). For instance,
rth-Gomer et al. (32) reported that following myocardial
nfarction (MI), women with concomitant marital stress had
higher frequency of recurrent cardiac events during a
ve-year follow-up compared to those with less marital
tress. These data are supported by a recent study that found
higher prevalence of subclinical atherosclerosis, and accel-
rated progression over time, among healthy women report-
ng marital dissatisfaction (Fig. 3) (34), supporting the
ssertion that marital stress is atherogenic.
Caregiving strain is an increasingly prevalent stressor that
as recently been studied for potential cardiovascular se-
uelae (35,36). In the Nurses’ Health Study, caregiving for
n ill or disabled spouse was associated with a nearly twofold
djusted risk ratio for experiencing an adverse cardiac event
uring a four-year follow-up period (35). However, this
eport did not stratify patients based on the emotional
ppraisal of their caregiving experience. Because other
esearch indicates that highly meaningful and altruistic
xperiences can be of psychologic benefit (37), it is possible
hat the effects of caregiving are dependent on the meaning
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Psychosocial Factors and CAD March 1, 2005:637–51ttached to such activities. In support, another study ob-
erved that when caregivers were divided into those with
nd without a sense of emotional strain during caregiving,
nly those reporting strain had an increased death rate
uring follow-up (36).
lustering of psychosocial risk factors. Although we have
iscussed emotional factors and chronic stressors as separate
ntities, they frequently cluster. For example, individuals
ho experience job strain tend to have higher rates of
epression compared to those who do not report strain (38).
he strong overlap between chronic stress and emotional
actors suggests that any life situation that has the capacity
o evoke chronic negative emotional responses may promote
eart disease. For instance, a recent study found that
hildhood maltreatment (39) was associated with a signifi-
ant increase in both depression and cardiovascular disease
mong adult women. Similarly, exposures ranging from the
eath of a child to adverse wartime experiences may poten-
ially affect the risk of CAD development and should be
andidates for study.
omparison of psychosocial risk factors with traditional
AD risk factors. The characterization of psychosocial
isk factors as “major” CAD risk factors has been debated.
owever, more consistent and reproducible outcome stud-
es confirm that psychosocial risk factors such as depression,
oor social support, and low SES represent potent CAD
isk factors. Furthermore, many reported studies now link
sychosocial risk factors to the presence of subclinical
therosclerosis or its progression, as measured by carotid
ltrasonography (5–8,29–31,34,40,41). Meta-analyses of
sychosocial studies have been limited by the use of varying
easures and inconsistent methods for calculating risk
atios. However, a recent meta-analysis of outcomes asso-
igure 3. Postmenopausal females (n  390) were divided into those in
nd in low-satisfying marriages (right of each panel). After 11 years of
n unsatisfying marriages had the highest percentage of significant plaqu
n a subgroup of this patient population (n  206) and revealed that wo
uring follow-up (right panel). Reprinted with permission from Gallo
 0.05.iated with depressive symptoms indicates a relative risk
c
Hhat is comparable to those noted for traditional CAD risk
actors reported from the Framingham study (Fig. 4) (3,42).
This observation is supported by the recently reported
NTERHEART case-control study, which uniquely as-
essed eight coronary risk factors and a composite index of
sychosocial factors within a single standardized interna-
ional population of 12,461 acute post-MI patients and
4,637 matched controls gathered from 52 countries (43).
he psychologic index was necessarily limited by the study’s
esign to either brief or even single-item assessments of
epression, locus of control, perceived stress at home or
ying marriages (left of each panel), unmarried (middle of each panel),
w-up, the women in satisfied marriages had the lowest and the women
t panel). Serial carotid ultrasonography was performed after three years
in low-satisfying marriages also had the greatest progression of plaque
Psychosom Med 2003;65:952– 62 (34). *Groups differ significantly at
igure 4. The risk ratios for traditional risk factors reported for men in the
ramingham study (28). The risk ratios for depressive symptoms and
linical depression are from a recent meta-analysis by Rugulies et al. (3).
he risk ratios for traditional risk factors are for death due to cardiac
isease, myocardial infarction, coronary artery insufficiency, and develop-
ent of angina. For depressive symptoms and clinical depression, the risk
atios are for death due to cardiac disease and myocardial infarction. CI satisf
follo
e (lef
menonfidence interval; HT  hypertension; LDL  low-density lipoprotein;
DL  high-density lipoprotein.
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March 1, 2005:637–51 Psychosocial Factors and CADork, moderate to severe financial stress, and experience of
dverse life events. Nevertheless, the odds ratios and
opulation-attributable risk for acute MI by this limited
ubjective measure of psychosocial stress was substantial,
omparable to those noted for other major CAD risk factors
Fig. 5). In addition, this psychosocial index remained a
obust predictor of MI independent of geographic or ethnic
ontext (26).
Moreover, for a variety of reasons, the risk associated with
sychosocial factors may actually be greater than such
tatistical evidence suggests. First, behavioral and metabolic
isk factors tend to aggregate disproportionately among
ndividuals with psychosocial stress (1). However, this
otentially powerful effect is reduced because of the statis-
ical convention to adjust psychosocial risk ratios for behav-
oral and metabolic risk factors. Second, because measures
f psychosocial stress may be imprecise, they may underes-
imate the relationship between psychosocial stress and
AD outcomes. For example, although depressive disorders
re generally episodic, the scales used to measure self-
eported depressive symptoms assess only the presence of
elatively current depressive symptoms. Thus, it is not
urprising to find that the chronicity and level of depressive
ymptoms are together more strongly associated with mea-
ures of atherosclerosis compared with symptom levels alone
igure 5. Risk of acute myocardial infarction for men and women for each
NTERHEART case-control study. Results are adjusted for age, gender,
or controls and cases in the third and fourth columns; prevalence rates are
odel. Reprinted with permission from Yusuf et al. Lancet 2004;364:937–
dds ratio; PAR  population-attributable risk; Smok  smoking; Veg 40). Third, psychosocial risk factors tend to aggregate. euch clustering is associated with an increased likelihood of
ardiac events (1) and more subclinical atherosclerosis (8,9).
uture epidemiologic directions. In contrast to the data
inking negative emotional states and chronic stress to
AD, the potential protective effect of positive psychologic
actors has not been extensively investigated. Building on
ork in other areas, we suggest that one potential direction
or clinical investigations in this neglected area could be to
xplore the notion of flexibility as it relates to mental health
44). In the physical domain, the ability to demonstrate
ariability in response to stressors may be associated with
etter clinical outcomes (45). Similarly, having the capacity
o respond to situations in a variety of different ways (i.e., to
exibly adapt one’s emotional and coping responses to any
iven situation) may be associated with better mental health.
e consider three psychologic components that may be
entral to developing emotional and coping flexibility (Fig.
). One key component is “vitality,” which refers to the
resence of energy and enthusiasm and a sense of aliveness
46). It is characterized by two positive emotions, joy and
nterest, and is fueled by both a sense of purpose and a sense
f self-worth. Vitality may be considered both restorative
nd regenerative and, as such, connotes a sense of freshness
nd positive excitement. Conversely, when someone lacks
itality, the likelihood of becoming excited and investing
e coronary artery disease (CAD) risk factors evaluated in the international
eographic location. The prevalence of each CAD risk factor is presented
alculated for the psychosocial (PS) index as it is derived from a statistical
3). Abd  abdominal; CI  confidence interval; Curr  current; OR 
tables.of nin
and g
not cnergy toward goals and in interactions with others is
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Psychosocial Factors and CAD March 1, 2005:637–51iminished. The availability of this energy promotes two
ey adaptive responses (which may in turn promote vitality):
evelopment of various positive response mechanisms (such
s patience, discipline, and maintaining friendships) and
motional competence, or the ability to regulate emotions
cross a range of situations (47). An important aspect of
motional competence is the ability to either enhance or
uppress emotional expression, a trait that may be termed
emotional flexibility,” as discussed by Bonanno et al. (48)
nd others.
From this perspective, depression and various exhaustive
tates can be viewed as a long-term deficit in vitality and an
scalating inability to be flexible and responsive to life and
aily challenges. Anxiety and anger can also be viewed as
motionally inflexible responses, with the constant negative
motions dissipating energy and taxing positive coping
echanisms. Job strain is also an excellent example of a
ituation that can drain energy and vitality. For example, a
ecent study has demonstrated that chronic job strain can
ead to exhaustion and an inability to unwind after work
28). Such sequelae can increase the risk for adverse cardiac
vents (49). By contrast, professional, marital, interpersonal,
nd avocational activities that require effort but that also
romote joy and interest serve to preserve vitality and
exibility.
Early emotional theorists suggested that positive emo-
ions such as joy might provide recuperative power. Support
or this concept is provided by recent data showing that
ositive psychologic factors can dampen physiologic reac-
ivity to negative emotional stimuli (50). Similarly, individ-
als who score high on the trait of forgiveness (51) or who
re provided with social support (52) demonstrate lower
eart rate and blood pressure elevations during laboratory
igure 6. The mental health paradigm in which individuals who have a
trong sense of purpose coupled with a sense of self-worth derive benefit in
erms of a greater sense of vitality. The positive emotion associated with
itality provides energy needed to develop and maintain greater emotional
ompetence and positive response mechanisms. In turn, the presence of
motional competence and positive response mechanisms provide a stabi-
izing force for maintaining a sense of vitality.ental stress. Other data indicate that positive emotions can cnhance immune function (53). Evaluation of the impact of
ositive psychologic factors upon clinical outcomes is also
imited and recent. In the largest study to date, Kubzansky
t al. (54) conducted a 10-year follow-up study of 1,306
en from the Normative Aging Study, who were assessed
or optimistic versus pessimistic “explanatory style” (i.e.,
ow one explains the causes of bad events). Stratification of
ndividuals according to optimistic, neutral, and pessimistic
xplanatory styles revealed a gradient relationship between
evels of optimism and cardiac outcomes, with optimism
alving the risk for cardiac events. A separate measure of
ispositional optimism has been linked to more favorable
utcomes following bypass surgery (55). A strong relation-
hip has also been noted between positive emotions and
ongevity in the long-term follow-up of nuns whose diaries
n early adult life were assessed for positive emotional
ontent (56). Such findings suggest the value of further
xploring positive psychologic factors that may promote
ealth or protect against disease.
ATHOPHYSIOLOGY
motional disturbance and chronic stress can have a pro-
ound impact on the central nervous system, including
ncreased output from the sympathetic nervous system and
he HPA axis. Chronic stimulation from these central
utputs can induce a wide variety of pathophysiologic
esponses, as displayed in Figure 7. Depression has been
articularly studied in this regard. Chronic stimulation of
he HPA axis by depression frequently results in hypercor-
isolemia, blunted HPA activity, and diminished feedback
igure 7. Pathophysiologic mechanisms by which chronic stress and
ffective disorders, such as depression, appear to promote atherosclerosis.
hese stressors activate the hypothalamic-pituitary-adrenal (HPA) axis
nd the sympathetic nervous system (SNS) and affect behaviors. Multiple
dverse peripheral effects can ensue from this neuroendocrine, sympathetic,
nd behavioral activation, as shown. The neuroendocrine and neuroplastic
hanges emanating from these stressors can also induce a state of
eightened physiologic responsivity to acute stress which may interact with
hronic stressors to cause more adverse effects. ANS  autonomic nervous
ystem; Endo.  endothelial.ontrol, as evidenced by nonsuppression of cortisol secretion
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March 1, 2005:637–51 Psychosocial Factors and CADollowing dexamethasone suppression. When present, hy-
ercortisolemia is associated with suppression of growth and
ex hormones. Heightened stimulation of the sympathetic
ervous system is also common in depression and is asso-
iated with higher concentrations of circulating plasma
orepinephrine and an increase in total body sympathetic
ctivity (57). As a consequence, depressed patients com-
only manifest higher resting heart rates than healthy
ontrols and exhibit autonomic nervous system dysfunction,
ncluding diminished heart rate variability, baroreflex dys-
unction, and increased QT variability (57).
Hypercortisolemia, in association with blunted growth
nd sex hormones, promotes central obesity (58), which
ay occur despite overall weight loss, and an increase in
eripheral and portal fatty acids. These metabolic changes
lso contribute to more insulin resistance and diabetes
mong depressed subjects, and a higher frequency of dia-
etic complications (59). Depressed patients manifest sub-
tantial platelet abnormalities, including increased concen-
rations of beta-thromboglobulin and platelet factor 4 and
ncreased concentration of functional glycoprotein IIb/IIIa
eceptors. In addition, there is evidence that depression is
ssociated with a hyperactive 5-hydroxytryptamine (5-HT)
ransporter2A receptor signal transduction system and, re-
atedly, increased responsiveness of platelets to serotonin
60). Other recent studies indicate that depression is asso-
iated with increases in C-reactive protein, interleukin-6,
umor necrosis factor, and other inflammatory proteins (61).
he potential mechanism for this association may be com-
lex, involving not only stimulation of the HPA axis and the
ympathetic nervous system but also potential synergy in-
uced by peripheral effects, such as hyperglycemia (62).
ore recent data indicate that depression is associated with
heightened incidence of endothelial dysfunction among
arious cohorts, including young and otherwise healthy
epressed patients (63). Finally, depression is also associated
ith decreased bone mineralization, which is the result of
ncreased cortisol and decreased concentrations of growth
nd sex hormone concentrations, and probable interaction
ith local inflammatory proteins. Thus, depression is capa-
le of inducing virtually the full spectrum of pathophysio-
ogic effects noted in Figure 6.
uture research directions. Because other psychosocial
isk factors have not yet been investigated as extensively as
epression, the full spectrum of their pathophysiologic
ffects requires further study. In addition, we highlight three
reas where clinical observations provide new research
irections. First, the observation that cardiac event rates
ncrease when psychosocial risk factors cluster has focused
nterest on explanatory mechanisms. Whether this increase
s due to greater overall stress or the synergistic effects of
tressors that evoke different pathophysiologies needs to be
etermined. The latter possibility is supported by recent
ata indicating distinct pathophysiologic differences accord-
ng to the exposure of Watanabe Heritable Hyperlipidemic
abbits to two different chronic stressors: an unstable social invironment versus social isolation. Both forms of stress
roduced more atherosclerosis compared to a control group,
ut the groups exposed to different forms of stress exhibited
ifferent metabolic consequences and patterns of accrued
therosclerosis (64).
Second, various data suggest links between chronic psy-
hologic distress and certain adverse behaviors, such as
vereating (65,66). New technologies that study brain
unction suggest that such links may be centrally mediated.
mmunohistochemistry has been used to identify an ana-
omic chronic stress response network, localized to several
pecific brain centers, in a rat model of chronic stress (67).
hereas glucocorticoids help end acute stress responses by
xerting negative feedback upon the HPA axis, glucocorti-
oids occupy central glucocorticoid receptors during chronic
tress, with resultant activation of the chronic stress re-
ponse network, including continued glucocorticoid produc-
ion, in these experimental animals (66,67). This combina-
ion of chronic stress and high glucocorticoid levels appears
o stimulate a preferential desire to ingest sweet and fatty
oods (66). Further study indicates that glucocorticoids
ffect dopaminergic transmission in areas of the brain
ssociated with motivation and reward (68). Positron emis-
ion tomography (PET) has been used to identify the
resence of diminished dopamine D2 binding potential
ithin midbrain systems under conditions of chronic stress
n the cynomolgus monkey (69). In humans, PET studies
ave revealed that this area is involved specifically in food
otivation (70), and that, like stressed monkeys, obese
ndividuals also have decreased D2 receptor function in this
ame reward area of the brain, varying inversely with body
ass index (71).
Third, data suggest that enhanced physiologic reactivity
o acute stress is clinically important, linked to subclinical
therosclerosis (72,73) and interacting with known psycho-
ocial risk factors to produce greater degrees of subclinical
therosclerosis (41). Clinical observations suggest that
hronic stress, per se, may be an important cause for such
nhanced physiologic reactivity (as exemplified in Fig. 7).
or instance, depressed (57), hostile (74), and low-SES
ubjects (19) all manifest exaggerated physiologic responses
o acute stressors. These observations are complemented by
xperimental animal studies that indicate that repeated
xposure to a chronic stressor results in increased adrenal
nd pressor responses to acute novel stressors (66,75). Other
nimal research indicates that the mimicking of chronic
tress by experimentally elevating glucocorticoids within the
rain produces enhanced adrenocorticotropic hormone re-
ponses (76) and increases in both baseline arterial blood
ressure (77) and blood pressure and heart rate responses to
n acute novel stressor (78). Research that further eluci-
ates the neurophysiology of the chronic stress circuitry,
nd the mechanisms of neuroplasticity that produce
ong-term stress-induced changes in the control of phys-
ologic functions, could pave the way for understanding
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ardiovascular disease.
ACTORS LINKING PSYCHOSOCIAL
ISK FACTORS AND CARDIAC PRACTICE
s illustrated in Figure 8, there are important reasons that
ardiologists should be interested and skilled in recognizing
nd managing psychosocial risk factors in practice. We have
lready discussed two compelling reasons: psychosocial risk
actors are strongly linked to the development of adverse
ardiac events and cluster with adverse behaviors that
romote CAD. We now discuss four additional factors that
ink psychosocial risk factors to cardiac practice.
First, psychosocial risk factors are highly prevalent within
ardiac populations. For instance, the National Comorbid-
ty Survey (79) assessed the frequency of serious psychiatric
llness and found that the 12-month and lifetime prevalence
ates of certain depressive and anxiety disorders, as well as
erious substance abuse, were remarkably high, with 48%
eporting at least one of these disorders in their lifetime. To
ompare these prevalence rates with those noted in general
edical and CAD populations, it is also useful to examine
oint prevalence rates, the percentage of persons with
sychiatric disorders at a specific point in time. For example,
he prevalence rate of major depression disorder in the
ational Comorbidity Survey was approximately 5%, com-
ared with a prevalence of 15% or greater in populations
ith CAD (1). In addition, at least another 15% to 20% of
atients with cardiac disease exhibit depressive symptoms
hat do not necessarily meet criteria for major depressive
isorder (1). Similarly, anxiety disorders, such as phobic
nxiety or panic disorder, are relatively common among
atients with CAD. As a consequence, cardiologists are
ikely to encounter a significant number of psychologically
istressed patients in clinical practice.
Second, psychologic distress commonly presents as symp-
igure 8. Six reasons that promote interest in the evaluation and manage-
ent of psychosocial stress in cardiac practice.oms of cardiac disease in clinical practice. Notably, whereas tertain psychosocial risk factors such as depression and
nxiety can present with either psychologic and/or somatic
anifestations, it is those with primarily somatic symptoms,
uch as chest pain or palpitations, who seek medical evalu-
tion preferentially, thus exacerbating this tendency. In fact,
stimates indicate that more than three-fourths of patients
ith major depression or panic disorder seen in primary care
ettings present with somatic complaints only (80,81).
ecause chest pain and palpitations are common somatic
omplaints, a high proportion of patients presenting with
uch symptoms in medical settings have psychologic distress
n the absence of objective evidence of organic heart disease.
or instance, whereas panic disorder occurs in 4% of the
eneral population (79), it occurs in more than 15% to 20%
f patients presenting with chest pain complaints in emer-
ency departments, reflecting the high rate of medical care
se by these patients (82). Physician awareness of these
elationships is important, because psychologic distress is
requently underdiagnosed in medical evaluations of cardiac
ymptoms. For example, in a prospective evaluation of 441
atients presenting to a cardiac care emergency department
ith chest pain and evaluated blindly for psychiatric diag-
osis, approximately 25% had panic disorder, but in 98% of
he patients with panic disorder, the diagnosis was missed
y the cardiologists in the cardiac care emergency depart-
ent (83).
Third, psychosocial risk factors can adversely affect treat-
ent adherence. For instance, a meta-analysis has demon-
trated that patients with depression were three times more
ikely to be nonadherent with treatment recommendations
84). Similarly, a recent meta-analysis of 122 social support
tudies (85) has revealed that patient adherence is strongly
nfluenced by the magnitude of adequate functional or
tructural social support. However, although it seems intu-
tively reasonable, it has not yet been conclusively demon-
trated that alleviation of psychologic distress improves
reatment adherence.
Fourth, acute psychologic stress shapes the course of
ardiac disease in both positive and negative fashion. On the
ne hand, acute emotional stress represents an important
rigger for exacerbating pathophysiologic processes, ranging
rom the induction of endothelial dysfunction to the pre-
ipitation of myocardial ischemia. The latter occurs during
aboratory mental stress in approximately 50% of patients
ith exercise-induced ischemia (1). On the other hand,
atients’ experience of acute cardiac events and premonitory
ymptoms, such as angina pectoris, is itself a form of acute
sychologic stress that can sometimes transform patients’
ives by signaling a need for personal reflection, inducing a
eevaluation of values and/or shifting the perspective of time
rom “years since birth” to “years remaining” (86). Such
vents may cause patients to be more receptive to adopting
ew attitudes and be more successful in altering unhealthy
ehaviors, as indicated by various studies. Because cardiol-
gists commonly treat patients who experience acute life-
hreatening events and who may be more receptive to
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March 1, 2005:637–51 Psychosocial Factors and CADhysician advice, cardiologists may be ideally positioned to
nitiate these interventions.
DENTIFICATION AND
ANAGEMENT OF PSYCHOSOCIAL RISK FACTORS
iven that psychologic distress is often first detected in
linical health care settings, the cardiologist can play a
ritical role in the identification and management of psy-
hosocial risk factors. This role can be divided into three
road categories: screening for psychosocial risk factors,
eferring of appropriate patients to behavioral health care
roviders, and managing milder forms of psychologic dis-
ress in the context of clinical practice.
creening for psychosocial risk factors. Cardiologists can
ncrease the detection of psychosocial risk factors by sys-
ematically screening for them. Querying patients about
sychosocial risk factors conveys the message that these
actors are important and relevant to providing optimal care.
creening can be accomplished by structured interviews
nd/or by validated questionnaires. Although questionnaire
easures are easily administered and objectively scored,
nterviews allow greater flexibility and offer richer clinical
nformation than that provided by written inventories.
ecause cardiologists are accustomed to obtaining medical
istories through a brief review of systems, additional
uestions about psychosocial risk factors could easily be
ncorporated into such assessment. These questions should
over three kinds of experiences that may help to identify
sychologic distress: 1) emotional factors, such as depres-
ion, anxiety, and anger; 2) chronic stressors, such as work
train and home stress; and 3) somatic complaints that may
e stress-related, such as fatigue and disrupted sleep. Some
uestions for screening patients’ psychosocial status are
uggested in Table 1.
The identification of emotional distress can often be
hallenging in the medical setting. Hallmarks of disorders
uch as depression (e.g., changes in appetite and/or signif-
cant changes in weight) and panic disorder (e.g., palpita-
ions, and/or shortness of breath) can indicate either a
ardiac or psychiatric condition. Inaccuracy in determining
he cause of such symptoms can result in misdiagnosis and
istreatment. Moreover, because physicians’ time is often
imited, psychosocial problems need to be assessed relatively
uickly and efficiently. However, research suggests that such
kills can be learned and effectively implemented. Finally,
ollowing acute events or surgical interventions, cardiac
atients may feel especially vulnerable and helpless. During
uch times, inquiries about mental health and psychosocial
unctioning can be perceived as highly threatening, and may
licit defensiveness, resentment, and denial. The cardiolo-
ist can help preempt this response by openly addressing the
atient’s concerns and establishing rapport.
eferring patients to behavioral health care providers.
he benefits of screening for psychosocial risk factors will beealized only if proper identification leads to appropriate mntervention and follow-up. Patients with apparently signif-
cant psychologic distress or behavioral maladjustment
hould be referred to appropriate specialists for counseling
nd/or psychiatric treatment (87). Thus, part of the cardi-
logist’s role in managing psychologic distress may be the
evelopment of a referral network of specialists. However,
lose follow-up of patients even after referral is highly
dvisable because early dropout from both pharmacotherapy
nd psychotherapy is common (87).
anaging psychologic distress in clinical practice. Sub-
linical presentations of psychologic distress, such as minor
epression, work stress, inability to relax, and difficulty
leeping, may be appropriately handled in routine cardiac
ractice. Tools that are readily available to cardiologists for
irect management of psychosocial risk factors are practical
ehavioral interventions, as outlined in Table 2. Cardiolo-
ists are familiar with some of these interventions, such as
xercise and nutritional counseling, but physicians may
nderestimate the potential effectiveness of such counseling
echniques (88) and the other tools listed in Table 2.
As for the treatment of obesity, poor nutritional habits,
moking, and sedentary lifestyles, patient non-adherence
an complicate physician attempts to modify psychosocial
isk factors. Helping patients to initiate behavior change is
hallenging, requiring mastery of techniques and approaches
erived from psychology and the behavioral and social
ciences, and recommendations stemming from the Amer-
can Heart Association’s Expert Panel on Compliance (89).
epresentative techniques that cardiologists can use to
romote patient adherence are summarized in Table 3. For
xample, the use of “micro goals” for poorly adherent
atients, such as those who may claim to not have the time,
illingness, or belief that they can exercise, can be applied.
n such patients, initiating a modest exercise program
equiring only 5 to 10 min of walking per day may be useful,
ncreasing exercise at a measured pace. All new behaviors
epresent transitional intentional practices that initially re-
uire more intense physician monitoring and personal
eedback before becoming more automatic and habitual.
ecause no single approach is effective for all patients,
astery of multiple approaches and diverse strategies may
mprove behavioral adherence rates typically reported in
linical practice.
Although mastery of techniques to promote adherence
able 1. Suggested Open-Ended Questions to Screen for
sychosocial Risk Factors
. How would you describe your energy level?
. How have you been sleeping?
. How has your mood been recently?
. What kind of pressure have you been under at work or at home?
. What do you do to unwind after work or at the end of the day? Do
you have difficulty unwinding?
. Who do you turn to for support?
. Are there any personal issues that we have not covered that you
would like to share with me?ay be highly desirable, these add to the time, diligence,
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Psychosocial Factors and CAD March 1, 2005:637–51raining, and complexity required to manage multiple risk
actors in cardiac practice. As a consequence, cardiologists
ay rely on a nurse or other qualified office personnel, an
rganized community or hospital program, and/or comple-
entary instructional material to assist them in managing
sychosocial risk factors, particularly for the more intense
nterventions noted in Table 3.
able 2. Behavioral and Medical Interventions for Psychosocial R
Type of Intervention Targeted Condition
xercise training Psychologic distress Exercise
utritional counseling Management of stress
by overeating
Provide n
elaxation training General stress and stress
caused by specific
situations
Advise pa
provide
instruc
tress management General stress and stress
caused by specific
situations
Recomm
relaxin
activiti
ocial support Poor structural or
functional support
Provide s
walkin
altruist
ealth information Specific stress situations
(e.g., at work or
home) or low health
literacy
Provide s
form o
audiota
Most amenable to direct cardiologist management.
able 3. Steps to Promote Effective Adherence to Behavioral
uggestions
1. Use clear and effective communication, including making
recommendations that are as specific and simple as possible.
2. Schedule follow-up visits to check adherence, especially during the
early practice phase, as opposed to the later, more ingrained habit
phase.
3. Provide a motivating rationale for the patient’s treatment regimen,
with consideration of explanations that befit the patient’s health
literacy.
4. Follow oral suggestions with written ones to reinforce the
cardiologist’s message and aid memory and concentration.
5. Begin with “micro” goals for patients who are resistant to behavior
change or who have fewer available personal resources.
6. Help patients establish realistic goals and expectations.
7. Involve patients in tailoring behavioral suggestions rather than
dictating change.
8. Suggest activities that are commensurate with patients’ abilities and
that provide positive feedback (factors that tend to promote a sense
of pleasure).
9. Openly and candidly explore potential patient barriers to adherence
(such as lack of personal motivation, time, family support, facilities,
or knowledge; fears; job, home or other pressures; and cultural
issues) and assist patients with problem-solving and developing
strategies (e.g., self-monitoring approaches, written agreements, and
relapse prevention) at the time of recommendations.
0. Refer patients with poor structural or functional social support to
programs or activities that will enhance adherence by providing(social support.esults of behavior and psychopharmacologic interven-
ion trials. A variety of behavioral and psychosocial inter-
entions have been implemented in cardiac patients, includ-
ng exercise training, psychosocial interventions as part of
ultifactorial risk factor modification, organized psychoso-
ial interventions designed to reduce psychosocial risk fac-
ors, and psychopharmacotherapy. The results of cardiac
utcome studies involving these approaches are reviewed
ere.
Exercise is commonly recommended by cardiologists to
romote both primary and secondary CAD prevention, but
vidence suggests that exercise may also modify psychosocial
isk factors, including depression. For instance, cross-
ectional studies of both medical populations and healthy
ohorts have consistently demonstrated lower depression
cores among those who are most active. The ability of
xercise to reduce depression also has been demonstrated in
andomized controlled trials, although many of these studies
ave had methodologic limitations (90). More recently, a
andomized controlled comparison between antidepressant
edication versus exercise was performed in a group of 156
en and women with depression (91). After 16 weeks,
xercise was just as effective as sertraline hydrochloride in
educing depressive symptoms. Follow-up of these patients
fter six months revealed a low rate of relapse in the exercise
roup (92). Although the study may have had some meth-
dologic limitations, these intriguing data suggest the need
or additional prospective trials.
The utility of organized psychosocial interventions has
een most commonly assessed by evaluating their incremen-
al impact upon prognosis among patients referred to formal
ardiac rehabilitation programs. For instance, Linden et al.
actors
Intensity of Intervention
Less Intense* More Intense
iption plus general guidelines Supervised exercise
onal advice Supervised dietary instruction,
weight management, and
behavior modification
to initiate relaxation training;
otapes, videotapes, or
scripts
Teach muscle relaxation, imagery,
autogenic training,
diaphragmatic breathing, or
biofeedback.
cations, hobbies, yoga,
ic, pets, or pleasurable
Teach behavioral strategies (e.g.,
problem-solving, self-
monitoring, appropriate goal-
setting, relapse-prevention
techniques)
c social suggestions (e.g., join
ps or engage in socially
ivities)
Use staff as a support base, enroll
patient in support group, or
facilitate family involvement
n-specific information in
k, articles, pamphlet,
ideotapes, or Web sites
Discuss and answer patient
questions regarding materials
related to health and treatment
recommendationsisk F
prescr
utriti
tient
audi
tional
end va
g mus
es
pecifi
g grou
ic act
ituatio
f boo
pes, v93) performed a meta-analysis of 23 randomized controlled
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March 1, 2005:637–51 Psychosocial Factors and CADrials that evaluated the impact associated with adding
sychosocial interventions to standard cardiac rehabilitation
egimens. During the first two years of follow-up, lack of
sychosocial intervention was associated with greater rates
or mortality and recurrent infarction. In a separate meta-
nalysis of psychosocial interventions and cardiac rehabili-
ation, Dusseldorp et al. (94) observed differential effects
epending on the efficacy of the psychosocial intervention.
hen psychologic distress was reduced, the odds ratio for
ortality and recurrent MI also was reduced, but when no
eduction in psychologic stress occurred, mortality was
igher in intervention than in control rehabilitation pa-
ients. Along these lines, recent data suggest that the failure
o respond to psychosocial interventions may identify a
ubgroup of patients who are particularly susceptible to
dverse clinical events (95).
The utility of stand-alone psychosocial interventions has
lso been evaluated in five large-scale behavioral interven-
ion trials in cardiac patients, with mixed results. The
ecurrent Coronary Prevention Project Study was a group
herapy behavior modification program that succeeded in
ecreasing both Type A behavior and negative affect and
lso reduced the rates of cardiovascular mortality and
onfatal MI (96). The Ischemic Heart Disease study was a
econd successful intervention trial, using a unique home-
ased stress-reduction program to reduce cardiac events
97). Two other large trials did not reduce subsequent
ardiac events in the treatment groups, but neither inter-
ention successfully reduced psychosocial distress (98,99).
n fact, one of these trials was a follow-up of the approach
sed in the Ischemic Heart Disease trial, and secondary
nalysis of the data from this trial revealed that the results
ould be attributed to inadequate psychologic intervention
n the experimental group (100). Indeed, cardiac mortality
as significantly reduced at one year among the subgroup of
xperimental treatment patients who experienced an early
eduction in psychologic distress. The Enhancing Recovery
n Coronary Heart Disease Patients (ENRICHD) study
as the fifth and largest stand-alone psychosocial interven-
ion trial to date. It evaluated the effect of psychologic
reatment on the composite end point of all-cause mortality
nd nonfatal MI in post-MI patients who were either
epressed and/or who reported low perceived social support
101). Patients were randomized within four weeks of the
ndex MI, and treatment consisted of individual cognitive
herapy and, when possible, group therapy supplemented by
he use of a selective serotonin reuptake inhibitor (SSRI) for
evere or unremitting depression. Primary analyses found no
reatment differences in event-free survival (101). However,
nalyses suggested only a modest difference in psychosocial
unctioning between the treatment and control groups.
sychosocial functioning was better than anticipated in the
ontrol group, perhaps due to aggressive treatment as part of
outine medical care, including participation in cardiac
ehabilitation and psychologic therapies, thereby reducing
reatment group differences. bThe paucity of stand-alone behavioral intervention trials
s partly due to the large sample sizes, long follow-up, and
igh costs required of such trials. One way to reduce this
roblem would be to use a three-stage approach for devel-
ping future interventions (Fig. 9) based on initial evalua-
ions of surrogate end points, such as measures of subclinical
therosclerosis, myocardial ischemia, or flow-mediated di-
ation in smaller samples. Although there are limitations to
he use of surrogate end points, they can be effective for
eveloping new and innovative interventions for CAD
efore launching large multicenter randomized trials.
The impact of psychopharmacologic therapies upon car-
iac outcomes represents an area of new interest. An initial
rial in this arena, the Sertraline Antidepressant Heart
ttack Randomized Trial (SADHART), demonstrated
hat an SSRI (sertraline) could be safely prescribed for the
reatment of clinical depression in patients with known
AD (102). However, this trial was not powered to evaluate
he influence of sertraline use on adverse cardiac events, as
t was a safety study. Cohen et al. (103) assessed antide-
ressant use in a large group of union health plan members
ivided into those who were taking antidepressants and
hose who were not. Participants using tricyclic antidepres-
ants had a more than a twofold increased risk of subsequent
I, but there was no increase in adverse cardiac events
mong the patients taking SSRIs. A recent case-control
tudy suggests that the protective effect of SSRIs may be
elated to their degree of serotonin transporter affinity (104).
f confirmed, these findings suggest that SSRIs with high
erotonin transporter affinity may be the preferred pharma-
ologic means for treating depression in CAD patients
igure 9. Proposed three-stage approach for developing behavioral inter-
ention trials. Stage 1 consists of a single-center evaluation of a specific
ehavioral intervention. If successful, this intervention would be repeated at
ultiple centers to assess the reproducibility of findings (stage 2). In both
tages, intermediate end points, such as change in carotid intimal wall
hickening or plaque size during carotid ultrasonography, would be used to
inimize necessary sample size and follow-up time. If reproducible results
re obtained during stage 2, a multicenter intervention trial would be
erformed in stage 3, during which subjects would be observed for the
ccurrence of hard cardiac events. IMT  intima medial thickness.ecause of a biologic antiplatelet effect. A biologic protective
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Psychosocial Factors and CAD March 1, 2005:637–51ffect for depressed patients also may be introduced by the
se of statin therapy, as suggested by preliminary data
ndicating that statin therapy lowers the high levels of
-reactive protein associated with depression (105).
uture directions in behavioral interventions. Although
linical practice guidelines advocate psychosocial interven-
ions in the context of cardiac rehabilitation programs, there
re no existing recommendations to guide the delivery of
sychosocial interventions in cardiac practice. Cardiac reha-
ilitation programs are widely recognized as effective in
roviding multifactorial multidisciplinary treatment for car-
iac patients (106), but these programs are geographically
imited and third-party reimbursement policies may limit
atient participation. Overall, only 10% to 20% of eligible
ardiac patients are referred to cardiac rehabilitation pro-
rams (106). Thus, these programs represent an incomplete
elivery system for behavioral health care in cardiac practice.
oreover, because of time constraints and lack of formal
raining in behavioral techniques, many cardiologists may
nd it difficult to provide psychosocial interventions to their
atients. In addition, even though cardiologists commonly
anage behavioral risk factors, such as physical inactivity,
oor diets, and smoking, lack of patient adherence to their
ehavioral recommendations remains an important problem
89) for which there is no easy solution. For all these
easons, development of effective models for the provision of
sychologic and behavior services for cardiologists is
eeded.
Accordingly, programs of various complexities have been
xamined for their ability to improve physician management
f behavioral risk factors. These programs include providing
rief targeted physician training, monitoring patients by
elephone follow-ups, using nurse managers in cardiology
ractice, and involving patients’ primary care physicians in
ollaboration with mental health professionals such as psy-
hologists and psychiatrists. This latter approach has shown
romise for optimizing primary care physician management
f serious psychologic illnesses such as depression (107) and
anic disorder (108). Although critical assessment of these
pproaches is beyond the scope of our review, a conceptual
pproach for organizing behavioral health care interventions
or cardiac patients, based on the collective experience
arnered from these approaches, is shown in Figure 10. In
his approach, guidelines would be developed for stepped
ollaborative care interventions, based on the complexity of
atients’ psychosocial and behavioral problems and their
bility to adhere to behavioral recommendations.
The difficulty in maintaining long-term behavioral
hange among cardiac patients, coupled with the growing
pidemic in obesity and type 2 diabetes, makes it imperative
o develop more effective adherence strategies. Bellg (109)
uggests that standard efforts to optimize treatment adher-
nce most commonly view nonadherence as a form of
atient deficit that can be overcome by using external forms
f behavioral regulation, such as use of incentives or
tructured provider support (Fig. 11). Such controlled be-
r
favior regulation may be very effective in eliciting short-
erm behavioral change, but fostering patient autonomy is
ritical to maintain long-term change (110). Conversely,
ack of internal motivation is a primary reason why patients
ontinue to engage in unhealthy shortsighted behaviors after
eing informed about the long-term adverse consequences.
pproaches for fostering internal motivation are suggested
n Figure 11. An approach that incorporates many of these
rinciples is “motivational interviewing,” which is designed
o enhance patients’ intrinsic motivation to change un-
ealthful behaviors by exploring and resolving ambivalence
igure 10. Stepped collaborative care for cardiac patients depending on the
egree of psychological distress. Patients with mild psychologic distress
step 1) would generally be treated by cardiologists without additional
ollaborative intervention. The greater the degree of psychosocial distress,
he greater the need for collaborative intervention.
igure 11. Approaches to promoting treatment adherence commonly
ake use of techniques that involve external regulation, such as the use of
ncentives or external network support. An alternative motivational para-
igm to such controlled behavior regulation focuses on attempts to
romote autonomy by fostering greater intrinsic motivation. Health
roviders can foster this motivational process through a variety of steps,
ncluding promoting patient ownership over recommended behavioral
hanges (i.e., getting patients to voice their own reasons for initiating
hange), helping patients to find a meaningful purpose for suggested
hanges, formatting the specifics of behavior recommendations in a manner
ost consistent with patients’ personal preferences, and recognizing what
oping mechanisms were best served by the old adverse behaviors (e.g.,
ating to decrease a sense of tension) and finding alternative solutions. At
he same time it is important to avoid ignoring a sense of conflict (which
an occur if behavioral recommendations are made without considering the
elationship of physician advice to patients’ internal values and preferences),
ostering a sense of coercion, or setting goals that are not readily achievable.
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March 1, 2005:637–51 Psychosocial Factors and CADo change (111). In this approach, the interviewer uses
mpathy to help patients focus on discrepancies between
resent behavior and long-term aspirations and values, and
voids confrontation or playing an authoritarian role. This
pproach has been applied to various behavior settings (99),
nd is promising for treating cardiac patients. Other novel
trategies also may be used to create “teachable moments,”
or example, by showing patients personally relevant clinical
mages of calcium deposits in their coronary arteries (112).
o date, this motivational approach has not yet been tested
n a sufficiently broad spectrum of patient populations.
HE EMERGING FIELD OF BEHAVIORAL CARDIOLOGY
ehavioral cardiology is an emerging field of clinical prac-
ice based on the recognition that adverse lifestyle behaviors,
motional factors, and chronic life stress can all promote
therosclerosis and adverse cardiac events. In recent years,
he pathophysiologic understanding of how psychosocial
isk factors contribute to atherosclerosis and adverse cardiac
vents has broadened substantially. By contrast, the devel-
pment of effective therapeutic interventions both for mod-
fying high-risk lifestyles and behaviors and for reducing
sychosocial risk factors for CAD patients remains a chal-
enge. There have been few large-scale psychosocial inter-
ention trials, and the design of future trials is under debate.
oreover, the lack of patient adherence to behavioral
nterventions remains a significant problem. Nevertheless,
here is increasing evidence that interventions such as
xercise training, multifactorial secondary prevention efforts
hat incorporate psychosocial interventions, and antidepres-
ant medication may be effective in treating psychologic
istress and improving outcomes among patients with
ardiac disease. Other preliminary evidence suggests that
tress management programs can improve surrogate markers
or CAD. Prospective investigations are needed to deter-
ine which patients may respond best to specific forms of
ehavioral interventions and also define how cardiologists
an best collaborate with other health care providers and
ealth care delivery systems to reduce psychologic distress in
cost-effective and practical manner. The field of behavioral
ardiology requires the development of such practical solu-
ions because the etiologic links among psychosocial risk
actors, behavioral risk factors, and atherosclerosis suggest
hat cardiologists will consistently encounter many patients
ith psychologic distress and unhealthy behaviors in clinical
ractice.
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